Clinical Trials

Other solid neoplasmThoracic

37 enrolled

Mesothelioma

NCT07480733 2026-03-25

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

480 enrolled

Advanced Malignant Solid Tumors

NCT06827054 2026-03-24

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

20 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07332312 2026-03-16

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

71 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT06771739 2026-03-13

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

20 enrolled

Malignant Solid Neoplasm

NCT07192315 2026-03-13

PREDICTO

160 enrolled

Solid Tumor Malignancies

NCT07469982 2026-03-13

A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors

122 enrolled

Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion

NCT07459920 2026-03-10

CAPTURE

156 enrolled

Advanced Malignant Solid Tumor

NCT07450352 2026-03-04

SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

150 enrolled

Unresectable Solid Tumors

NCT07446725 2026-03-03

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

152 enrolled

Advanced Solid Tumor Cancer

NCT07437625 2026-02-27

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

90 enrolled

High-Burden Metastatic Solid Tumors

NCT07438093 2026-02-27

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

Advanced Solid Tumors

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

GastrointestinalGynecologicOther solid neoplasmThoracic

24 enrolled

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

Solid Tumors

NCT07234058 2026-02-11

LAG-MAPS

Other solid neoplasmThoracic

126 enrolled

Mesothelioma, Malignant

NCT07396090 2026-02-09

Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

13 enrolled

Advanced Solid Tumor

NCT07385950 2026-02-04

Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors

Not yet recruiting

100 enrolled

PET / CT

NCT06772090 2026-02-03

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

40 enrolled

Solid Tumor, Adult

NCT07363369 2026-01-23

Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

NCT07356856 2026-01-21

Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors

Advanced and Relapsed Solid Tumors

NCT07342738 2026-01-15

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

KRAS G12V

NCT07333664 2026-01-12

Image-Guided 125I Seed Implantation Plus Standard Systemic Therapy for Patients With Multiple Metastatic Lesions

120 enrolled

Metastatic Solid Tumors

NCT07325123 2026-01-08

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

30 enrolled

Solid Tumor Malignancies

NCT07327411 2026-01-08

Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors

40 enrolled

Advanced Refractory Solid Tumors

NCT07318649 2026-01-06

Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation

120 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07307053 2025-12-29

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Other neoplasmOther solid neoplasm

600 enrolled

Rare Malignant Neoplasm

NCT05522491 2025-12-11

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

30 enrolled

Solid Tumor

NCT07274657 2025-12-10

SMILE

EndocrineGastrointestinalNETOther solid neoplasm

150 enrolled

Pancreas Adenocarcinoma (MSI-H)

NCT07257497 2025-12-02

Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol

20 enrolled

Solid Tumor Cancer

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Solid Tumor

NCT07178938 2025-11-14

THERANOVA

BreastOther solid neoplasm

Solid Tumors

NCT06895681 2025-11-10

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

Not yet recruiting

50,000 enrolled

Solid Tumor

NCT07207681 2025-10-06

Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors

30 enrolled

Advanced Solid Tumors

NCT06027983 2025-09-23

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

BreastOther solid neoplasm

36 enrolled

HER2+ Advanced Breast Cancer

NCT07182435 2025-09-19

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

36 enrolled

Solid Tumor Malignancies

NCT07170787 2025-09-12

A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors

104 enrolled

Advanced Solid Tumors

NCT07128576 2025-09-04

Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors

Solid Tumors

NCT07155811 2025-09-04

T-ECHNICO

100 enrolled

Immunotherapy

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Other solid neoplasmThoracic

55 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT07127822 2025-08-17

Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer

GastrointestinalOther solid neoplasm

106 enrolled

Gastric / Gastroesophageal Junction Adenocarcinoma

NCT07124195 2025-08-15

Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting

Phase 3 Not yet recruiting

126 enrolled

Malignant Solid Tumors

NCT07101549 2025-08-03

Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)

Advanced Solid Tumors

NCT07046780 2025-07-02

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

Not yet recruiting

90 enrolled

Solid Tumor Cancer

NCT07038044 2025-06-26

Safety and Efficacy of an Arginine-Restricted Diet in Patients With Solid Tumors

Solid Tumor Cancer

NCT07028047 2025-06-19

Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study

64 enrolled

Advanced EBV-positive Malignant Solid Tumors

NCT07013851 2025-06-10

NADIA

GynecologicOther solid neoplasm

MMRd/MSI-H Stage II-III Endometrial Cancer

NCT06991478 2025-05-28

SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

Solid Tumor, Malignant Ascites

NCT06970132 2025-05-14

Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation

102 enrolled

Advanced Solid Tumor

NCT06951425 2025-05-13

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

24 enrolled